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receptor sequences in Transgenic 
rats expressing a human B cell 
repertoire in response to Tetanus 
Toxoid and Measles antigens
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Emilie Charpentier, Regina Sinner, Anke Wienecke-Baldacchino and Claude P. Muller*
Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg
The identification and tracking of antigen-specific immunoglobulin (Ig) sequences within 
total Ig repertoires is central to high-throughput sequencing (HTS) studies of infections or 
vaccinations. In this context, public Ig sequences shared by different individuals exposed 
to the same antigen could be valuable markers for tracing back infections, measuring 
vaccine immunogenicity, and perhaps ultimately allow the reconstruction of the immuno-
logical history of an individual. Here, we immunized groups of transgenic rats expressing 
human Ig against tetanus toxoid (TT), Modified Vaccinia virus Ankara (MVA), measles 
virus hemagglutinin and fusion proteins expressed on MVA, and the environmental 
carcinogen benzo[a]pyrene, coupled to TT. We showed that these antigens impose a 
selective pressure causing the Ig heavy chain (IgH) repertoires of the rats to converge 
toward the expression of antibodies with highly similar IgH CDR3 amino acid sequences. 
We present a computational approach, similar to differential gene expression analysis, 
that selects for clusters of CDR3s with 80% similarity, significantly overrepresented within 
the different groups of immunized rats. These IgH clusters represent antigen-induced 
IgH signatures exhibiting stereotypic amino acid patterns including previously described 
TT- and measles-specific IgH sequences. Our data suggest that with the presented 
methodology, transgenic Ig rats can be utilized as a model to identify antigen-induced, 
human IgH signatures to a variety of different antigens.
Keywords: transgenic rats, B cell repertoire, next-generation sequencing, repertoire convergence, public cDr3s, 
airr-seq, Deseq2
inTrODUcTiOn
Immunoglobulin (Ig) molecules are the primary effectors of the humoral immune response. In 
theory, Ig can bind to every possible antigen through the large variety of Ig V (variable), D (diver-
sity), and J (joining) gene rearrangements in the bone marrow (BM) and target-oriented affinity 
maturation in germinal centers (1). All B cells of a germinal center are clonally related to a common 
Abbreviations: ALUM, aluminum hydroxide; BaP, benzo[a]pyrene; BaP-TT, benzo[a]pyrene tetanus toxoid conjugate; BM, 
bone marrow; EPT, endpoint titers; F, fusion glycoprotein of the measles virus; FDR, false discovery rate; H, hemagglutinin 
glycoprotein of the measles virus; HF, hemagglutinin and fusion protein of the measles virus; HTS, high-throughput sequenc-
ing; IgL, immunoglobulin light chain; IMGT, ImMunoGeneTics database; MV, measles virus; MVA, Modified Vaccinia virus 
Ankara; ROSIE, Rosetta Online Server that Includes Everyone; TT, tetanus toxoid; VST, variance stabilizing transformation.
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ancestor and target the same antigen with varying affinities, 
iteratively selecting for improved affinity and avidity (2). The Ig 
molecules of the emerging B cells bind to the target epitope in a 
lock-and-key principle which is mediated mainly by the heavy 
chain complementary-determining region 3 (CDR3) loop on 
top of the Ig (1, 3). The CDR3 is the most variable part of the 
Ig sequence and the main antigen-binding determinant. The 
repertoire of CDR3s sufficiently describes the entire functional 
Ig heavy chain (IgH) repertoire of an individual (3, 4).
High-throughput sequencing (HTS) has been widely applied 
to study the IgH repertoire in response to vaccination and infec-
tion (5). With this technique, it has become possible to investigate 
the evolutionary affinity maturation processes after antigenic 
challenge and to compare their outcome across individuals (6). 
The IgH repertoire is essentially private (7), but it appears that 
individuals also produce a public response to a common antigenic 
stimulus characterized by a certain degree of similarity at the 
CDR3 sequence level (8–11). Public CDR3s were notably identi-
fied in human in response to dengue infection, H1N1 seasonal 
influenza vaccination, and repetitive polysaccharide antigens (5, 
11, 12). Such CDR3s provided signatures of past immunological 
exposures allowing for sequence-based monitoring of vaccination 
or infectious diseases, and perhaps ultimately to reconstruct an 
individual’s antigenic history. Studies investigating this concept 
of public Ig CDR3s mainly used human blood-derived PBMCs. 
These represent only a miniscule part of the complete Ig reper-
toire (13), and it is critical to capture the affinity-matured B cells 
during their brief transit from the germinal centers through 
peripheral blood to the BM. The large heterogeneity of human 
B cell repertoires composed of past exposure to a plethora of anti-
gens further complicates the identification of antigen-induced Ig 
sequences in the context of single antigen challenge or vaccina-
tion (14). The usage of an animal model provides ready access 
to secondary lymphoid organs after restricted antigen exposure, 
enabling a focused investigation of antigen-experienced plasma 
cells (15–17).
Here, we applied HTS on class switched, BM B  cells, rich 
in serum antibody producing plasma cells, from rats carrying 
human germline IgH and light chain (IgL) loci, the OmniRat™ 
(18–21). These transgenic rats were immunized with viral 
(Modified Vaccinia virus Ankara, MVA), protein [measles 
virus (MV) hemagglutinin and fusion proteins, HF, and tetanus 
toxoid (TT)], and chemically defined hapten–conjugate antigens 
(benzo[a]pyrene-TT, BaP-TT) to study the evolution of conver-
gent CDR3 amino acid sequences. We showed that OmniRat™ 
mount convergent Ig responses characterized by CDR3s with 
high amino acid sequence similarity. The level of similarity was 
consistent for all investigated antigens. We applied an approach 
similar to differential expression analysis to identify overrepre-
sented clusters of highly similar, antigen-driven CDR3s. These 
could be grouped into antigen-associated signatures matching 
previously described MV-specific OmniRat™ hybridomas (22) 
and human TT-specific antibodies (12, 23–25). Our results sug-
gested that humanized Ig transgenic rats can be used as a model 
to study human-like Ig repertoire dynamics and to determine 
antigen-associated CDR3 signatures to characterize the history 
of antigen exposure in human individuals.
MaTerials anD MeThODs
animals and immunizations
Humanized Ig transgenic rats (OmniRat™, Open Monoclonal 
Technology Inc., Palo Alto, CA, USA) were developed and bred 
as previously described (18–21). OmniRat™ carry a chimeric 
human/rat Ig heavy chain locus, where 22 human IgHV genes 
and all human IgHD and IgHJ genes are linked to the rat IgHC 
genes in germline configuration as well as fully human, Ig light 
chain lambda, and kappa loci (20) (Table S1 in Supplementary 
Material). A total of 32 animals were separated into six groups 
of four to six individuals. They received three intraperitoneal 
injections at 2-week intervals and were sacrificed 7  days after 
the last injection. Injections either contained 100  µg of TT 
(TT group, n = 4; Serum Institute of India, Pune, India) or of a 
BaP-TT conjugate construct (BaP-TT group, n =  5) (26), both 
formulated with 330 µg of aluminum hydroxide (ALUM). Other 
rats were injected with 107 PFU of a recombinant MVA expressing 
the hemagglutinin (H) and fusion (F) glycoproteins of the MV 
(MVA-HF group, n =  6) or the MVA viral vector only (MVA 
group, n =  6) without adjuvant. The control animals received 
either 330 µg of ALUM alone (ALUM group, n = 6) or were left 
untouched (NEG group, n = 5). Antigen-specific IgG responses 
were monitored by ELISA 10  days after immunizations and at 
sacrifice. All animal procedures were in compliance with the 
rules described in the Guide for the Care and Use of Laboratory 
Animals (27) and accepted by the “Comité National d’Éthique de 
Recherche” (Luxembourg).
antigens for immunization and elisa
BaP was coupled to ovalbumin (OVA, Sigma-Aldrich) for ELISA 
and to purified TT as previously described (26). The recombinant 
MVA and the recombinant MVA carrying MV H and F proteins of 
the Edmonston strain [MV vaccine strain, clade A] viruses were 
propagated on BHK-21 cells (ATTC™ CCL-10™) as previously 
described (28–30). Antigen-specific IgG antibody levels in sera 
were determined in 384-well microtiter plates (Greiner bio-one, 
Wemmel, Belgium), coated overnight at 4°C with either 250 ng 
of MV antigen (Measles grade 2 antigens; Microbix Biosystems, 
Mississauga, ON, USA), 2.5  ×  105 PFU of sonicated MVA 
(~314 ng), 187.5 ng of TT, or 0.25 µM of BaP-OVA in carbonate 
buffer (100 mM, pH 9.6). Free binding sites were saturated with 
1% bovine serum albumin in Tris-buffered saline at room tem-
perature for 2 h. Serial dilutions of the sera were added for 90 min 
at 37°C and developed with alkaline phosphatase-conjugated 
goat anti-rat IgG (1/750 dilution; ImTec Diagnostics, Antwerp, 
Belgium) and the appropriate substrate. Absorbance was meas-
ured at 405 nm. End point titers were determined as the serum 
dilutions corresponding to five times the background.
sample Preparation, amplification, and 
ionTorrent PgM sequencing
Lymphocytes were isolated from BM samples by density-gradient 
centrifugation (ficoll® Paque Plus; Sigma-Aldrich). Total RNA 
was extracted from 108 cells with an RNeasy midi kit following 
the manufacturer’s protocol (Qiagen) and enriched for mRNA 
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using paramagnetic separation (μMACS mRNA Isolation kit; 
Miltenyi Biotec, Leiden, Netherlands). cDNA was prepared from 
300 ng of mRNA using dT18 primers and Superscript III reverse 
transcriptase (Thermo Fisher Scientific) at 50°C for 80  min. 
Recombined IgH fragments were subsequently amplified by 
multiplex PCR using primers for human IgHV region and rat 
Cγ region with Q5 Hot Start High Fidelity polymerase (NEB, 
Ipswich, MA, USA) as described previously (22). Amplicons 
were size selected on a 2% agarose gel and quantified. Quality 
was checked with a Bioanalyzer (High Sensitivity DNA, Agilent 
Technologies, Diegem, Belgium). Four randomly selected librar-
ies were pooled in equimolar concentrations and sequenced on a 
318™ Chip v2 (Thermo Fisher Scientific) using multiplex identi-
fiers (MIDs) with the Ion OneTouch™ Template OT2 400 Kit and 
the Ion PGM Sequencing 400 Kit (Thermo Fisher Scientific) on 
the Ion Torrent Ion Personal Genome Machine (PGM™) System 
(Thermo Fischer Scientific).
Quality control and sequence annotation
BAM files were extracted from the Torrent Suite TM software 
(version 4.0.2, standard settings) and demultiplexed by MIDs. 
Only reads with an unambiguously assigned MID (0 mismatch), 
identified primers at both ends (two mismatches allowed) and 
more than 85% of the bases with a quality score above 25 were 
considered for further analysis. After clipping MIDs and primers, 
sequences were collapsed and submitted to the ImMunoGeneTics 
database (IMGT) HighV-QUEST web server1 (31) for IgHV gene 
annotation and CDR3 delineation (32). IgHV and IgHJ genes for 
the inframe, productive sequences were subsequently assigned 
using a local installation of IgBlast (33), including only the genes 
present in the genome of the OmniRat™ as references. Only 
sequences with an unambiguously assigned IgHV and IgHJ gene 
were considered for further analysis.
Human Ig sequences (IgG and IgM) were obtained from the 
Sequence Read Archive database2 and processed as described 
[Accession number: SRP068407 (34)]. Samples taken at day 
7 post immunization were excluded to avoid skewing of data 
distributions by the applied vaccination. Samples were annotated 
using IMGT and postprocessed using Change-O framework [v 
0.2.4 (35)]. Only functional sequences present at least three times 
per data set were considered for assessing CDR3 length distribu-
tions and somatic hypermutation level.
cDr3 similarity Threshold for Public 
immune responses
The number of matches for the 200 most frequent CDR3s (top 
200) of a rat A in a rat B was obtained for a series of similar-
ity thresholds and returned as ratio from 0 to 1 (i.e., all top 200 
CDR3s of rat A have a match in rat B). Ratios were determined 
from 50–100% sequence similarity in 1% increments. The aver-
ages for the top 200 matching ratios at each increment were then 
calculated for all rats within a vaccination group and all rats vac-
cinated with unrelated antigens. Rats with related antigens were 
1 www.imgt.org.
2 https://www.ncbi.nlm.nih.gov/sra.
excluded in the pairwise comparison (e.g., MVA as intragroup 
for MVA-HF). The average top 200 matching ratios were plotted 
against sequence similarity along with the first derivatives in 
GraphPad3 Prism 5.
identification of antigen-Driven cDr3 
clusters
Only CDR3s longer than four amino acids were included in the 
analysis. CDR3s with a minimum of 80% amino acid similarity 
were considered as relatives. One amino acid length difference 
was allowed, to account for insertion and deletions introduced by 
SHM and occasional differential CDR3-IgHJ region alignments 
by IMGT (36, 37). Length difference was penalized the same 
way as a substitution. For each CDR3, the cumulative count of 
all its 80% relatives per rat (CDR3 count) was calculated and 
stored in a fuzzy match count table. Data were imported and 
analyzed with DESeq2 according to the standard workflow for 
RNA-seq, treating CDR3 counts as expression values (38). Briefly, 
data were imported as a count-data matrix and converted into a 
DESeq2-object with conditions according to the antigens used 
for vaccination. Correct sample grouping was confirmed using 
variance stabilizing transformation count data (VST counts). 
Euclidian distance computation was performed on VST counts 
as described in the DESeq2 vignette (39). Principle component 
analysis plots were generated using the “PlotPCA” function on 
VST counts of the DESeq2 package. P-values were adjusted for 
multiple testing and to determine the false discovery rate (FDR) 
using Benjamini–Hochberg correction (39). Based on an FDR 
of 1%, overrepresented CDR3 sequences were extracted if their 
adjusted P-values were lower than 0.01. Log2-fold change cutoffs 
were determined manually per antigen group. The extracted 
CDR3 sequences were grouped using single-seed iterative clus-
tering based on maximum difference of 80% sequence similarity. 
All analytical scripts were written in Python 2.7 and R 3.2.3 (40).
3D Modeling
Selected Ig nucleotide sequences were uploaded to IMGT for 
annotation. Sequences were elongated to full length by adding the 
missing nucleotides from the closest germline gene as predicted 
by the IMGT algorithm. Full length sequences were submitted 
to the “Rosetta Online Server that Includes Everyone” [ROSIE4 
(41–43)], with enabled H3 loop modeling option. ROSIE-output 
PDB files of the grafted and relaxed models were visualized using 
PyMol5 [version 1.7.4 (44)].
resUlTs
high-Throughput sequencing of 
Omnirat™ igh mrna Transcripts
To study convergent IgH repertoires in response to vaccination, 32 
transgenic Ig humanized rats (OmniRat™) were immunized with 
different antigens (Table 1; TT, BaP-TT, MVA, and MVA-HF). 
3 www.graphpad.com.
4 http://rosie.rosettacommons.org/.
5 http://pymol.org.
TaBle 1 | Study design: antigen and vaccination groups.
antigen TT group MVa group controls
TT (4) BaP-TT (5) MVa (6) MVa-hF (6) alUM (6) neg (5)
Benzo[a]
pyrene
– x – – – –
TT x (x) – – – –
Measles 
virus H + F
– – – x – –
MVA – – x x – –
Alum x x – – x –
Group sizes are indicated in parentheses. TT used in the BaP-TT vaccination group 
was chemically modified during the coupling process and therefore does not present 
the same antigenic surface as native TT in the TT group.
FigUre 1 | Shared complementary-determining region 3 (CDR3s) in 
OmniRat™ pairs. Box–whisker plots represent the number of identical 
CDR3s shared between pairs of rats from different (369 pairs, orange), 
related (56 pairs, light blue), or the same vaccination group (71 pairs, green). 
More CDR3s were shared between rats from the same (P-value 3.4 × 10−14) 
or related (P-value < 2 × 10−16) antigen group than between rats of different 
antigen groups (Kruskal–Wallis test followed by Nemenyi post hoc test).
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ALUM was used as an adjuvant for TT and BaP-TT. Two control 
groups received either the adjuvant alone or were left untouched 
(NEG). All animals exhibited a specific antibody response 
against the immunizations and mock immunized (ALUM group) 
and non-immunized animals (NEG group) showed no detect-
able antigen-specific antibodies (Figure S1 in Supplementary 
Material). MVA-HF- and BaP-TT-vaccinated animals exhibited 
a specific immune response against the MVA vector or the TT 
carrier protein, respectively, albeit at lower levels than the animals 
immunized with these antigens only (Figure S1 in Supplementary 
Material). Rearranged heavy chain IgG genes were amplified 
from mRNA extracted from BM lymphocytes and sequenced 
on a HTS Ion Torrent PGM™ platform. A total of 37,473,982 
raw reads with MID were obtained (range: 850,298–1,879,372 
per animal, Table S2 in Supplementary Material). After quality 
control and annotation, on average 86,619 unique nt sequences 
per animal were retained for analysis. The rats expressed a diverse 
IgH repertoire, including varying frequencies of all human IgHV 
and IgHJ genes. All possible IgHVJ combinations were found in 
all vaccination groups with no bias in IgHV, IgHJ genes, or IgHVJ 
recombination usage. The CDR3 length distribution of rats was 
comparable to that of observed in human IgG B cells (34) and 
somatic hypermutation resulted in an average germline similarity 
of 97.27% (±1.9%, Figure S2 in Supplementary Material).
Unique and highly similar cDr3 
sequences in response to the same 
antigen
We first investigated to what extent rats that received the same 
antigen expressed the same CDR3 amino acid sequences. Pairs 
of rats from different vaccination groups (369 pairs) shared 
less CDR3s with each other than pairs of rats within the same 
group (71 pairs, P-value  <  2  ×  10−16, Kruskal–Wallis with 
Nemenyi post hoc test) or immunized with related antigens (56 
pairs, P-value = 3.4 × 10−14), indicating that mutual CDR3s are 
essentially induced by the immunizations (Figure 1). Among a 
total of 11,643 identical CDR3s (i.e., 100% similarity) that were 
shared by any set of two or more rats irrespective of the antigen, 
5,346 CDR3s (45.9%) were shared exclusively by animals of the 
same group and 1,912 (16.4%) were shared between animals 
immunized with a related antigen (TT and BaP-TT, MVA, 
and MVA-HF). Most of the CDR3s shared within groups were 
common to only two animals of the same group (6,467; 89.1% of 
CDR3s shared within groups only). CDR3s present in all animals 
of a group were rare (Table 2). For instance, only a single CDR3 
was shared between all 6 rats immunized with MVA-HF, and 3 
CDR3s were shared between all the 12 animals exposed to the 
MVA vector (combined MVA and MVA-HF group) (Table  2). 
However, multiple CDR3s, differing only by one or two amino 
acids, were shared by all animals within a vaccination group 
but not by animals from other groups (Table  3). Interestingly, 
these differences occurred preferentially at certain positions of a 
CDR3 amino acid sequence. This suggested that the vaccinations 
seemed to have induced identical CDR3s as well as clusters of 
highly similar CDR3s.
shared antigen-related cDr3s at 80% 
sequence similarity
We compared CDR3s within and across the different vaccina-
tion groups to estimate the degree of similarity between these 
antigen-related clusters. We determined which of the top 200 
CDR3s, representing on average 72.1 ± 7.6% of the repertoire of 
the rats (Figure S3 in Supplementary Material), of any rat A had a 
related CDR3 in a rat B either within the same group (intragroup 
comparison) or between groups (intergroup comparison) allow-
ing for a single amino acid substitution. The same analysis was 
repeated for two, three, and up to eight amino acid substitutions. 
The number of top 200 CDR3s found to be present in inter- and 
intragroup was plotted against the amino acid substitutions 
expressed as percentage of CDR3 length (Figure 2A; Figure S4 in 
TaBle 3 | Alignment of selected complementary-determining region 3 (CDR3) 
(≥80% similarity) shared by rats in the Modified Vaccinia virus Ankara (MVA)-HF 
group highlighting the amino acid variation across animals being predominant at 
certain positions of the CDR3.
MVa-hF-associated cDr3s no. of 
animals
A R I V G A T T E F D Y 6
– – – – – – – – D – – – 4
– – V – – – – – – – – – 4
– – A – – – – – – – – – 3
– – – – – – S – D – – – 2
– – V – – – – – D – – – 2
– – – – – – S – – – – S 2
– – A – – – S – – – – – 2
– – – – – – S – – – – C 2
– – – – – – S N – – – – 2
– – – – – D S – – – – – 2
– – G – – – – – – – – – 2
A R H R T Y Y Y G S G S P L F D Y 4
– – – – – F – – – – – – – – – – – 4
– – – – – – – – – – – – – P – – – 3
– – – – – – – – – – – – – H – – – 2
– – – – – H – – – – – – – – – – – 2
– – – – – – – F – – – – – – – – – 2
– – – Q – – – – – – – – – R – – P 2
– – – – – F – F – – – – – – – – – 2
– – – – – H – – – – – – – I – – – 2
– – – – – – – – – – – – – – – – P 2
– – – – – F – F – – – – – R – – P 2
– – – K – F – – – – – – – R – – – 2
– – – – – – – – – – – – – I – – – 2
– – – – – – – – – – – – – R – – – 2
TaBle 2 | Number of identical complementary-determining region 3 (CDR3s) 
shared between rats in the same vaccination group or immunized with related 
antigens.
group not 
shared
number of cDr3s shared by n  
animals per group
n = 2 3 4 5 6 7 8 9 10 11 12
BaP-TT 27,167 510 74 12 0 – – – – – – –
TT 27,317 988 75 15 – – – – – – – –
MVA 61,139 1,123 168 40 1 0 – – – – – –
MVA-HF 43,778 686 51 4 0 1 – – – – – –
NEG 33,675 455 37 3 0 – – – – – – –
BaP-TT + TT / 258 101 24 11 0 1 1 0 – – –
MVA + MVA-HF / 924 316 102 72 35 29 15 8 8 4 3
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Supplementary Material). The resulting sigmoidal curves showed 
a similar shape for all vaccination groups. In the exponential 
phase between 100% and 90–95%, intragroup overlap was higher 
than intergroup overlap. In the linear phase between 90–95% 
and 75%, overlap increased faster for the intergroup comparison. 
In the asymptotic phase below 75% similarity, both inter- and 
intragroup overlap leveled off toward 1, indicating that all top 
200 CDR3s of a rat had relatives in any other rat, irrespective 
of the antigen administered. The first derivatives of the curves 
showed that in all cases the inflection point was at around 80% 
(Figure 2B; Figure S4 in Supplementary Material). Thus, at this 
similarity threshold a maximum number of related CDR3s can 
be found within the same group while keeping the number of 
related CDR3s between groups at a minimum. In conclusion, all 
antigens induced in these rats a public IgH response that can best 
be characterized by clusters of CDR3s with at least 80% similarity.
hierarchical clustering of cDr3 
repertoires at 80% sequence similarity
Based on the above observation, we identified antigen-driven 
CDR3s using a workflow developed for differential gene expres-
sion analysis of RNA-seq data (38). For each CDR3 within a rat, 
counts of CDR3 sequences with 80% similarity (CDR3 counts) 
were used analogous to RNA-seq read counts. Rats of the same 
vaccination group were considered as replicates. The CDR3 
counts followed a negative binomial distribution (Figure S5A in 
Supplementary Material). Compared to RNA-seq data, CDR3s 
usually lack a baseline expression and are essentially private, 
resulting mostly in zero counts for individuals across the study, 
while some shared CDR3s have very high counts in a single 
animal (Figure S5B in Supplementary Material). To account for 
this distribution, we applied VST to the CDR3 counts reducing 
the variance of the SDs over ranked mean values (Figure S5C 
in Supplementary Material). Hierarchical clustering of VST 
counts revealed three clusters (Figure  3A). Cluster I included 
all animals immunized with MVA (with or without MV HF 
protein expression). Interestingly, within this cluster, animals 
of the MVA-HF group and of the MVA group emerged from 
two separate branches indicating that additional presentation 
of HF antigens leaves a distinct imprint in the CDR3 repertoire. 
Cluster II contained the three groups of animals that received 
alum as an adjuvant (TT, BaP-TT, and ALUM). Again, each of 
the three groups clustered on separated sub-branches. Cluster III 
contained only untreated animals (NEG group) and was distinct 
from all immunized animals. The low variance and the specific 
grouping of the samples through both principle components 
showed that the VST counts cluster the data by the vaccination 
group. This indicated that the different antigens had distinct 
impact on a subset of the Ig repertoire of the rats (Figure 3B). 
When the data were reanalyzed applying an 85 or 75% threshold, 
the clear clustering of rats by vaccination group was lost (Figure 
S6 in Supplementary Material), thus confirming that the 80% 
similarity threshold was optimal to identify antigen-associated 
responses on the CDR3 repertoire of the rats. Additionally, it 
showed that VST CDR3 count data can be analyzed analogously 
to RNA-seq count data.
large numbers of antigen-associated 
cDr3s group into stereotypic signatures
Similar to RNA-seq expression experiments, we aimed to identify 
CDR3s that are differentially represented between groups of rats. 
Based on an FDR of 1%, 16,727 of the 249,657 (6.9%) unique 
CDR3s across all groups were found to be overrepresented. One 
hundred-fold differences in numbers of overrepresented CDR3s 
were identified in each of the six antigen groups (Table 4). The 
highest number of overrepresented CDR3s was found in the two 
combined groups MVA and MVA-HF (n = 11,080, 10.4% of the 
unique CDR3s for this combined group) and TT and BaP-TT 
TaBle 4 | Antigen-driven sequences and 80% similarity clusters.
Vaccination group antigen Overexpressed complementary-
determining region 3
no. of clusters (n > 10) Total clusters
Benzo[a]pyrene-tetanus toxoid (BaP-TT) Benzo[a]pyrene + tetanus toxoid (TT) 163 3 20
TT TT 540 14 46
Modified Vaccinia virus Ankara (MVA)-HF Measles virus H + F 804 13 79
MVA MVA 1,689 28 99
BaP-TT and TT TT backbone 2,451 25 63
MVA-HF and MVA MVA backbone 11,080 233 419
FigUre 3 | Sample grouping for 80% complementary-determining region 3 similarity counts. (a) Dendrogram of the Euclidian sample distances calculated for 
variance stabilizing transformation (VST) counts. Three main clusters are indicated by coloration (Cluster I: red, Cluster II: green, and Cluster III: blue). (B) Scatter plot 
for the first two principal components of VST counts. Samples are colored by vaccination-group [Modified Vaccinia virus Ankara (MVA): light blue, MVA-HF: green, 
tetanus toxoid: pink, benzo[a]pyrene-tetanus toxoid: gold, aluminum hydroxide: red, and NEG: blue].
FigUre 2 | Influence of complementary-determining region 3 (CDR3) sequence similarity on CDR3 repertoire overlap between rats. (a) Average fractions of top 200 
CDR3s of the Modified Vaccinia virus Ankara (MVA)-HF vaccination group shared with all CDR3s of other samples. Samples were divided into two groups having 
either the same antigen (MVA-HF group samples, blue curve) or different antigens (aluminum hydroxide, benzo[a]pyrene-tetanus toxoid, tetanus toxoid, and NEG 
samples, red curve), samples from overlapping antigens (in this case the MVA group) were excluded from this. Both curves follow a similar sigmoidal behavior. (B) 
First derivative of both curves. Inflection points align at 80% CDR3 amino acid similarity.
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(n = 2,451, 4.4%), which reflected the high immunogenicity of 
the antigens TT and MVA common within these groups. Less 
overrepresented CDR3s were found in the MVA (n  =  1,689, 
2.6%), the MVA-HF (n = 804, 1.8%), and TT group (n = 540, 
1.8%). The lowest number of overrepresented CDR3s was found 
in the BaP-TT group (n =  163, 0.6%). These overrepresented 
CDR3s could be considered group-specific and thus immuniza-
tion induced.
FigUre 4 | Antigen-associated complementary-determining region 3 (CDR3)-similarity clusters. The top five clusters of 80% similar CDR3s overexpressed in 
response to the antigens are shown as Weblogos. Coloration follows ImMunoGeneTics database amino acid coloration scheme (45). Numbers represent the unique 
CDR3s in each cluster. Average IgHV gene family usage (±SD) is indicated as percentage of sequences across all rats per cluster (see also Table S3 in 
Supplementary Material). IgHV2 was excluded, as no sequences in the clusters were derived from this family. (a) Clusters associated with the antigens benzo[a]
pyrene-tetanus toxoid (BaP-TT), tetanus toxoid (TT), and the combined antigen groups BaP-TT and TT. The red box indicates TT-associated OmniRat™ CDR3s 
bearing an amino acid pattern also found in human anti-TT PBMC CDR3 sequences for independent studies. (B) Clusters associated with the antigens Modified 
Vaccinia virus Ankara (MVA)-HF, MVA, and the combined antigens MVA and MVA-HF. The red box indicates measles virus (MV)-HF associated CDR3 signature also 
identified in OmniRat™ hybridomas generated in an independent experiment in response to MV antigens.
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Overrepresented CDR3s were grouped into clusters of 80% 
sequence similarity (Figure 4). The larger the antigen, the more 
clusters were found. For instance, 20 clusters were found for the 
BaP-hapten while 109 clusters were found for the TT protein (46 
for TT alone and 63 for TT and BaP-TT combined). The largest 
number of clusters was found for the MVA virus antigen (518, with 
99 for MVA alone, and 419 for MVA and MVA-HF combined). 
These complex antigen-driven clusters of CDR3s, typical for each 
FigUre 6 | OmniRat™ measles virus (MV)-specific complementary-
determining region 3 (CDR3) signature. The clusters of CDR3s 
overrepresented in response to Modified Vaccinia virus Ankara (MVA)-HF (see 
also Figure 4a), and the CDR3s from three monoclonal hybridomas specific 
for MV proteins are shown as Weblogos. The differences between the 
sequences were calculated as Levenshtein distances in percentage of CDR3 
length.
FigUre 5 | Fractions of the nucleotide immunoglobulin (Ig) repertoire encoding for complementary-determining region 3 (CDR3) signatures. The Ig repertoire per 
sample is displayed using numbers of full length nucleotide sequences. Nucleotide sequences encoding for CDR3s that are part of a signature are colored by 
associated antigen.
8
Bürckert et al. Ig Convergence in Transgenic Humanized Rats
Frontiers in Immunology | www.frontiersin.org December 2017 | Volume 8 | Article 1834
group, represented up to 46.5% of the BM IgH repertoire of the 
rats (Figure 5). The fraction of the repertoire corresponding to 
these CDR3 clusters varied between the groups but was relatively 
consistent among animals of the same antigen group.
Sequences encoding the overrepresented CDR3s were surpris-
ingly diverse in IgHV gene usage (Table S3 in Supplementary 
Material). IgHV genes belonging to one family were largely pre-
dominant for each cluster (average 93.3 ± 9.8% of genes belonging 
to one family per cluster), and the level of associated IgHV genes 
was comparable between rats of each cluster (Figure 4; Table S3 in 
Supplementary Material). Interestingly, cluster 2 of the combined 
group MVA + MVA-HF showed an elevated IgHV gene family 
repertoire. The dominant IgHV4 gene family accounted only 
for 57.5% (±20.4%) of the CDR3s, and the IgHV gene families 
IgVH1 (16.3  ±  13.4%), IgVH3 (14.2  ±  18.5%), and IgVH6 
(11.3 ±  11.6%) were predominating the cluster 2 repertoire of 
one, two, and one rat, respectively. All together we showed that 
OmniRat™ exhibited large fractions of highly similar, stereotypic 
CDR3s in response to the applied vaccinations, even across 
groups with shared antigens.
stereotypic signatures Match Known 
MV-specific and TT-specific cDr3s
Recombinant Modified Vaccinia virus Ankara expressing 
MVA-HF glycoprotein signatures were compared to the previously 
described CDR3s of MV-specific hybridoma clones derived from 
an independent set of OmniRat™ immunized with whole MV 
antigens (22). The largest of the identified HF-associated clusters 
(244 members) matched three CDR3s of MV-specific hybridoma 
cells, suggesting that this cluster is an MV-H or F protein-induced 
CDR3 signature (Figure 6). Similarly, our TT-associated clusters 
were compared to known human TT-specific IgH sequences (12, 
23–25). The CDR3s from the TT-associated cluster 4 matched 12 
published human CDR3s (Figure 7A). This OmniRat™ CDR3 
signature as well as the human CDR3s consisted of 15-mer CDR3s 
following the same amino acid pattern. Both humans and rats 
elicited a conserved paratope defined by a static motif “+QWLV” 
(+ = R/F; the “+” stands for the positively charged amino acids 
R and F) at the center of the CDR3, flanked by variable posi-
tions that are connected to the torso of the CDR3 (Figure 7B). 
This indicates that similar key positions are used even across 
species. The sequence similarity between the human and rat 
CDR3s ranged from 67 to 87% resulting from different torso 
amino acid compositions at the positions flanking the conserved 
binding motif (Figures 7C,D). To compare the structures of these 
CDR3s from human and rat origin, we performed 3D-homology 
modeling on their Fab fragments. Four human antibodies with 
available heavy and light chain sequences (24) and four selected 
OmniRat™ heavy chain sequences paired with the human 
light chains were modeled with Rosetta Antibody. Within the 
OmniRat™-human chimeric Fab fragments, the CDR3s formed 
torso structures ranging from unconstrained amino acid forma-
tions over short beta-sheets to rigid beta-sheet hairpin constructs 
(Figure 7C). Like the rats, human CDR3s exposed the key bind-
ing residues at the very tip of the CDR3 loop by a rigid beta-sheet 
hairpin formation of the torso that protruded out of the IgH core 
structure (Figure 7D). Together our results corroborate the evo-
lution of functionally convergent CDR3s in different individuals 
FigUre 7 | Omnirat™ and human antibodies against tetanus toxoid (TT) with similar properties and structures. (a) Sequence similarity range between OmniRat™ 
TT-associated cluster 4 (Figure 4B) complementary-determining region 3 (CDR3s) and human TT-specific CDR3s (Levenshtein distance as percentage of sequence 
length). (B) Amino acid pattern for the combined TT-specific human and TT-associated rat CDR3s. The Weblogo shows the conserved binding motif “+QWLV” (+ 
indicates K/R), and torso amino acids with variable positions are highlighted. (c) 3D-homology models of four OmniRat™-HC-human-LC chimeric antibody Fab 
fragments. Heavy chains are colored in orange and light chains in blue, both visualized with 50% transparent surface. CDR3 torsos are shown as cartoon and 
colored in red. Binding motifs are displayed as sticks and colored in green with only polar hydrogens shown. Views were enlarged to focus on the CDR3 structure. 
(D) 3D-homology models of four human Fab fragments visualized as described for (c). Motif, variable and torso structures are highlighted with boxes and arrows as 
described in (B).
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and by different vaccines delivering the same antigen. Also, this 
strongly indicates that OmniRat™ and humans, albeit the lower 
sequence similarity between their TT-associated CDR3s, produce 
antibodies with highly homologous CDR3s in response to the 
same antigen.
DiscUssiOn
We analyzed more than 2,700,000 functional IgH sequences 
derived from the BM of transgenic rats expressing human B cell 
receptor genes immunized with different antigens. Our study 
showed that these rats produced identical as well as highly similar 
CDR3 amino acid sequences in response to common antigenic 
challenges. When shared CDR3 repertoire fractions were investi-
gated at different levels of sequence similarity, overlaps between 
rats from the same vaccination group were optimal around 80% 
CDR3 amino acid similarity. Applying a differential gene expres-
sion workflow to the counts of 80% similar CDR3s, we presented 
a novel way to identify convergent, stereotypic CDR3 sequences 
in response to an antigenic stimulus. These included known 
CDR3s induced by different measles antigens, indicating that the 
identified CDR3s are specific for the MV H or F proteins which 
were shared in both immunizations. In addition, our approach 
also identified CDR3s in response to TT that were remarkably 
similar to known tetanus-specific CDR3s from human samples. 
Our findings highlighted the presence of convergent IgH tran-
scripts at high levels in the BM of the transgenic rats and that 
these sequences are highly similar to those of humans.
Pairs of rats within the same group shared more identical 
CDR3s than pairs from different groups, but very few CDR3s 
were shared among all rats of a group. Given the tremendous 
size and diversity of the Ig repertoire, finding identical sequences 
in several individuals is indeed unlikely (7). Because of private 
processes during B cell development including stochastic affinity 
maturation of the Ig molecules, a certain variability in CDR3s 
converging toward reactivity with the same antigen is to be 
expected (6, 46, 47). Galson et al. found that for the identification 
of public repertoires in humans an 87.5–91.6% cutoff (1 in 12 to 
1 in 8 amino acids) was optimal to identify TT- and influenza-
related CDR3 clusters (48). In the present study, we explored 
the relation between CDR3 sequence similarity and the overlap 
between CDR3 repertoires, by inter- and intragroup cross-
comparisons at different levels of sequence similarity. Our data 
showed that 80% amino acid similarity optimized the intragroup 
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overlap between CDR3 repertoires while keeping the intergroup 
overlap at a minimum. The identified antigen-associated clusters 
were absent in rats outside immunization groups, which provides 
a strong support for their underlying biological relevance.
We showed that between 6 and 46% of the BM IgH repertoire 
correspond to convergent CDR3 sequences. Similar proportions 
(15–50%) of antigen-specific CDR3 sequences were reported in 
peripheral blood B cells of patients with acute dengue infections 
(5). In contrast, in the reconvalescent dengue patients as well as 
in influenza patients, convergent sequences represented only less 
than 1% of peripheral B cell sequences. Such human studies are 
normally restricted to peripheral blood where only a small frac-
tion of the repertoire can be found and assessed (13, 49). Blood is 
the only readily available source for sampling B cells in humans. 
However, the high turnover rate of 5 × 1011 B cells per day (50) 
and low sampling depth make it difficult to capture a significant 
fraction for exhaustive analysis of antigen experienced Ig reper-
toires in a vaccination context (14, 51). In contrast, high levels of 
antigen-selected B cells can be found within the BM, where about 
17% of all B cells reside, making this tissue a preferable target for 
studying the antigen-specific B cell response after vaccination. In 
this regard, elevated levels (37%) of public clones were observed 
in mice in response to HBsAg and less to NP-HEL (22%) and 
OVA (14%), when examining BM-derived long-lived plasma cells 
(CD138+ CD22− MHCII− CD19− IgM− PI−) (14). In the present 
study, we analyzed Ig mRNA from bulk rat BM cell isolates, an 
organ rich in serum antibody-producing plasma cells (15–17). 
Because plasma cells express significantly higher levels of Ig 
mRNA [estimated 500:5:2 compared to memory or naïve B cells 
(52)] and only class switched BCR (IgG) were targeted, those are 
overrepresented in our data sets (47, 48). This explains the high 
fractions of converging CDR3s we found in the assessed BM IgG 
repertoire. We thus primarily targeted antigen-associated effec-
tor B cells, facilitating the tracking of antigen-specific sequences 
induced by similar antigens.
The IgH repertoire of OmniRat™ displayed a CDR3 length 
distribution comparable to that of human IgG B  cells isolated 
from peripheral blood and lower than that of the corresponding 
IgM B  cells (34). This indicates that OmniRat™ is generating 
CDR3 diversity in an equivalent way as humans. Interestingly, the 
average mutation rate of OmniRat™ IgG sequences was much 
lower as human blood-derived IgG or IgM B cells. This is most 
likely due to the much younger Ig repertoire of the rats having 
not been exposed to a large number of antigens as compared to 
humans, leaving their repertoires relatively unchallenged and 
thus unmutated (14).
The clusters of antigen-induced CDR3s exhibited a diverse 
IgHV gene usage from mainly one predominant IgHV gene family. 
Only CDR3 cluster 2 of the animals in the combined vaccination 
group MVA-HF + MVA exhibited significant differences in IgHV 
gene family usage across the rats. Similarly, different IgHV gene 
families were found in convergent CDR3 responses to Dengue 
infections and antipolysaccharide vaccination in humans imply-
ing a convergent evolution (5, 12). In an antigen–antibody binding 
scenario, the IgHV gene encodes for a structural scaffold while 
the CDR3 must precisely fit the antigen surface (3). Hoogenboom 
and Winter concluded from their synthetic antibody library 
that substitution of the CDR3 alone can create entirely different 
antibody specificities (53). However, in contrast to the other 29 
clusters, the 15-amino acid long signature of MVA-HF + MVA 
cluster 2 was largely composed of the IgJH 6 gene segment result-
ing in a tyrosine-rich “YYYGMDV” tail motif, with a shorter sec-
tion from the more diverse D/N region. Similarly, the signatures 
reported by Parameswaran and colleagues in response to Dengue 
were composed largely of a long, tyrosine-rich tail motif resulting 
from the IgJH region with very short D/N sections (5). We expect 
that such CDR3 signatures exhibit a rather polyreactive binding 
mediated by the abundant tyrosine residues. Yet, the absence of 
any 80% relatives in the other vaccination group underlines their 
presence as a result of the antigen exposure through the applied 
vaccination.
The varying IgHV gene assignments in each cluster can be 
explained by the relatively short read length of our approach. 
In this regard, IgHV genes belonging to the same family (e.g., 
IgHV4-39 and IgHV4-34) share a high level of similarity, only 
differing by few nucleotides. As the amplicons of the rat IgH 
transcripts did not span the whole IgHV sequence, information 
encoded in the FR1 and CDR1 are lost. This could easily lead to 
varying gene assignments, explaining the IgHV gene variability 
of the described CDR3 clusters.
Potential influence on the repertoire composition could result 
from PCR amplification biases introduced during library prepa-
ration as well as sequencing errors (54). We did not account for 
potential errors and sequencing bias by using molecular barcodes 
or similar methods (52, 55–57). However, the data analysis of 
the present study was based on collapsed, unique nucleotide Ig 
sequences, minimizing the influence of potential PCR amplification 
bias. Analysis of the nucleotide sequences before and after collaps-
ing to unique nucleotide sequences revealed no major difference in 
our findings, indicating that PCR amplification bias did not falsify 
our results. The IonTorrent PGM sequencing platform is prone 
to insertion and deletion errors, especially within homopolymer 
repeats (58). Such errors cause frameshifts within the Ig sequence 
which are detected by IMGT with 98% efficiency in a benchmarking 
setup, missing only indels at the beginning and end of the sequence 
or if placed in close proximity to each other masking the resulting 
frameshift (59). Sequences with detected indels are marked by 
IMGT as productive with detected errors and were not included in 
the described analysis. Furthermore, our analysis is based on the 
CDR3 amino acid sequence. An insertion or deletion within the 
CDR3 encoding nucleotides results in the sequence being labeled 
as unproductive, with no correction attempts undertaken by IMGT 
(59). Less than 1% of indel combinations remains undetected by 
IMGT and could be present within the CDR3 encoding nucleo-
tides (59). These rare combinations of sequencing errors would 
then result in artifactual CDR3s either covered by the applied 
80% sequence similarity clustering threshold or missed because of 
higher sequence variation. Therefore, such CDR3 artifacts can be 
expected to induce only a small underrepresentation of CDR3s by 
lowering CDR3 counts. In conclusion, the presented workflow is 
well protected from potential sequencing errors or PCR bias that 
could impact our conclusion.
We found that certain CDR3s have high counts of 80% rela-
tives within a group but very few to none in the unrelated groups. 
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This is in principle comparable to differential gene expression in 
RNA-seq data. The CDR3 counts followed a negative binomial 
distribution but, unlike in RNA-seq experiments, our data con-
tained large amounts of CDR3s with zero counts over different 
samples. These correspond to private CDR3s that are absent in 
other rats of the same or other groups. On the other hand, some 
CDR3s exhibited very high counts of 80% relatives within an 
animal. While such a data distribution is uncommon in RNA-
seq, they were nevertheless compatible with our computational 
approach [DESeq2 (38)], as demonstrated by negative binomial 
data distribution and perfect sample grouping after VST of the 
CDR3 counts. Interestingly, the Euclidian distance grouping 
of MVA-HF and MVA rats remained unchanged for 85% and 
even for 75% CDR3 counts in contrast to TT-associated rats. 
Similarly, Trück et  al. found highly similar (≤2 mismatches) 
Hib- and TT-related sequences enriched 7 days postvaccination, 
but could not identify H1N1- and MenC-related sequences at 
the same threshold (12). Correspondingly, statistical evidence 
of convergent CDR3s in pairs of donors against influenza with 
a mean genetic distance of ~75% was reported (60). Together 
with our data this indicated that the identification of convergent 
Ig repertoire responses using amino acid similarity thresholds 
was applicable. Future research will tell to what extent the 80% 
threshold can be applied to other antigens.
Identified convergent CDR3 matched to sequences of previ-
ously described human monoclonal antibodies against TT 
protein (12, 23–25). Despite the relatively low sequence similarity 
(67–87%) between OmniRat™ and human TT-specific CDR3s, 
they shared a common sequence and structural motif at the center 
of the CDR3. The center part of the CDR3 is exposed at the tip of 
the loop structure which directly interacts with the antigen while 
the adjacent amino acids act as a supporting scaffold. Similarly, 
Greiff and coworkers observed stereotypical motifs at the center of 
the CDR3 amino acid sequences in specific antibodies following 
NP vaccination in mice (14). While structural similarity cannot 
readily be used to determine antibody specificity, algorithms to 
identify convergent CDR3s could be further improved by includ-
ing structural parameters drawn from the expanding amount of 
available crystal structures.
In conclusion, we demonstrated a strong public IgH response 
with converging and overlapping CDR3 repertoires in animals 
exposed to the same antigens. These converging repertoires 
consisted of similar CDR3 sequences that can be best described 
using an 80% amino acid similarity threshold. Additionally, we 
presented an approach to identify such CDR3s by adopting a 
group-wise expression analysis, similar to RNA-seq approaches. 
This provides also a valuable tool for large-scale HTS data min-
ing to identify potential candidates for high-affinity targeted 
antibody design.
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